Page last updated: 2024-10-22

albuterol and Neutropenia

albuterol has been researched along with Neutropenia in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masclans, JR1
Barberà, JA1
MacNee, W1
Pavia, J1
Piera, C1
Lomeña, F1
Chung, KF1
Roca, J1
Rodriguez-Roisin, R1

Trials

1 trial available for albuterol and Neutropenia

ArticleYear
Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.
    American journal of respiratory and critical care medicine, 1996, Volume: 154, Issue:2 Pt 1

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Double-B

1996